Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia

(2020) Steven Y. C. Tong et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations

(2019) Pieter J. Colin et al.   CLINICAL PHARMACOKINETICS

Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program

(2019) Daniel J Diekema et al.   Open Forum Infectious Diseases

Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial

(2019) Amanda Gwee et al.   PEDIATRICS

Clinical and Pharmacokinetic Outcomes of Peak–Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial

(2019) Fatima Khalifa Al-Sulaiti et al.   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

Vancomycin Area under the Curve and Acute Kidney Injury: A Meta-analysis

(2019) Doaa M Aljefri et al.   CLINICAL INFECTIOUS DISEASES

Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model

(2019) Sean N Avedissian et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis

(2018) R. Diaz et al.   CLINICAL MICROBIOLOGY AND INFECTION

Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus

(2018) Nivedita B. Singh et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Removal of vancomycin administered during dialysis by a high-flux dialyzer

(2018) Heather A. Nyman et al.   Hemodialysis International

Variation of MIC measurements: the contribution of strain and laboratory variability to measurement precision

(2018) Johan W Mouton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

OUP accepted manuscript

(2018)   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Sustained improvement in vancomycin dosing and monitoring post-implementation of guidelines: Results of a three-year follow-up after a multifaceted intervention in an Australian teaching hospital

(2018) Cameron J. Phillips et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia

(2018) Chien-Fang Fu et al.   PLoS One

Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteremia

(2018) Bryan T. Mogle et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Making the change to area under the curve–based vancomycin dosing

(2018) Emily L. Heil et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

An Evaluation of Vancomycin Area Under the Curve Estimation Methods for Children Treated for Acute Pulmonary Exacerbations of Cystic Fibrosis Due to Methicillin-Resistant Staphylococcus aureus

(2018) Chris Stockmann et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Review and Validation of Bayesian Dose‐Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients

(2018) R. Brigg Turner et al.   PHARMACOTHERAPY

Interventions targeting the prescribing and monitoring of vancomycin for hospitalized patients: a systematic review with meta-analysis

(2018) Cameron J. Phillips et al.   Infection and Drug Resistance

Impact of Initial Vancomycin Trough Concentration on Clinical and Microbiological Outcomes of Methicillin-ResistantStaphylococcus aureusBacteremia in Children

(2017) Ree Nar Yoo et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions

(2017) Michael A. Pfaller et al.   Microbial Drug Resistance

Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support

(2017) Jeffrey J. Cies et al.   Pediatric Critical Care Medicine

Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients*

(2017) Sean N. Avedissian et al.   Pediatric Critical Care Medicine

Nephrotoxicity with Vancomycin in the Pediatric Population

(2017) Theresa M. Fiorito et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection

(2017) J. Chase McNeil et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing

(2017) Stephanie Natale et al.   PHARMACOTHERAPY

Evaluation of vancomycin MIC creep in Staphylococcus aureus

(2017) Raquel Diaz et al.   Journal of Global Antimicrobial Resistance

Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014)

(2017) Leonard R. Duncan et al.   Journal of Global Antimicrobial Resistance

Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates

(2016) Stéphanie Leroux et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats

(2016) Nathaniel J. Rhodes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship

(2016) Shigehiko Karino et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and Cefepime

(2016) Bhagyashri Navalkele et al.   CLINICAL INFECTIOUS DISEASES

Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis

(2016) A. Sinha Ray et al.   Clinical Journal of the American Society of Nephrology

Vancomycin toxicity in neonates

(2016) Jodi M. Lestner et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Healthcare-associated Staphylococcus aureus Bacteremia in Children

(2016) J. Chase McNeil et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Evaluation of weight-based vancomycin dosing for hospitalized hemodialysis patients

(2016) Rebecca Maxson et al.   RENAL FAILURE

Contemporary Vancomycin Dosing in Chronic Hemodialysis (HD) Patients Does Not Meet AUC Targets: Development of a New Dosing Model Using Monte Carlo Simulation (MCS)

(2016) Susan J. Lewis et al.   Open Forum Infectious Diseases

Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy

(2015) Chad A. Knoderer et al.   ANNALS OF PHARMACOTHERAPY

Association between Vancomycin Day 1 Exposure Profile and Outcomes among Patients with Methicillin-Resistant Staphylococcus aureus Infective Endocarditis

(2015) Anthony M. Casapao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A propensity-matched cohort study of vancomycin-associated nephrotoxicity in neonates

(2015) Jonathan E Constance et al.   Archives of Disease in Childhood-Fetal and Neonatal Edition

Bayesian Estimation of Vancomycin Pharmacokinetics in Obese Children: Matched Case-Control Study

(2015) Jennifer Le et al.   CLINICAL THERAPEUTICS

Pharmacokinetic Characteristics and Clinical Outcomes of Vancomycin in Young Children With Various Degrees of Renal Function

(2015) Huanian Zhang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients

(2015) Cady Ploessl et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Pharmacokinetics of Vancomycin in Extremely Obese Patients with Suspected or ConfirmedStaphylococcus aureusInfections

(2015) Eyob D. Adane et al.   PHARMACOTHERAPY

Assessment of Initial Serum Vancomycin Trough Concentrations and Their Association with Initial Empirical Weight-Based Vancomycin Dosing and Development of Nephrotoxicity in Children: A Multicenter Retrospective Study

(2015) Kelly L. Matson et al.   PHARMACOTHERAPY

Individualized Vancomycin Dosing in Obese Patients: A Two-Sample Measurement Approach Improves Target Attainment

(2015) Joseph Hong et al.   PHARMACOTHERAPY

Evaluation of Target Attainment of Vancomycin Area Under the Curve in Children With Methicillin-Resistant Staphylococcus Aureus Bacteremia

(2015) Andrea Hahn et al.   THERAPEUTIC DRUG MONITORING

Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application

(2015) S. Tafelski et al.   Journal of Infection and Public Health

Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients

(2015) Ola Abdel Hadi et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Innovative approaches to optimizing the delivery of vancomycin in individual patients

(2014) Manjunath P. Pai et al.   ADVANCED DRUG DELIVERY REVIEWS

Small Acute Increases in Serum Creatinine Are Associated with Decreased Long-Term Survival in the Critically Ill

(2014) Adam Linder et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Factors Associated With Acute Kidney Injury in Children Receiving Vancomycin

(2014) Elizabeth A. Sinclair et al.   ANNALS OF PHARMACOTHERAPY

Association between Vancomycin Trough Concentration and Area under the Concentration-Time Curve in Neonates

(2014) Adam Frymoyer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?

(2014) Thomas P. Lodise et al.   CLINICAL INFECTIOUS DISEASES

Vancomycin-Associated Nephrotoxicity in the Critically Ill

(2014) Timothy P. Hanrahan et al.   CRITICAL CARE MEDICINE

Comparison of the Incidence of Vancomycin-Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin-Tazobactam

(2014) Lindsey D. Burgess et al.   PHARMACOTHERAPY

Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or Cefepime

(2014) Diane M. Gomes et al.   PHARMACOTHERAPY

Vancomycin Monitoring in Children Using Bayesian Estimation

(2014) Jennifer Le et al.   THERAPEUTIC DRUG MONITORING

Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children

(2014) Jennifer Le et al.   Journal of the Pediatric Infectious Diseases Society

Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia

(2013) Natasha E. Holmes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?

(2013) Michael N. Neely et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Acute renal failure associated with vancomycin and β-lactams for the treatment of osteomyelitis in diabetics: piperacillin–tazobactam as compared with cefepime

(2013) R.P. Moenster et al.   CLINICAL MICROBIOLOGY AND INFECTION

A Stewardship Program’s Retrospective Evaluation of Vancomycin AUC24/MIC and Time to Microbiological Clearance in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis

(2013) Kristen M. Gawronski et al.   CLINICAL THERAPEUTICS

Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy

(2013) Cecilia Covajes et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion

(2013) J.J. De Waele et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Area under the concentration–time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia

(2013) Younghee Jung et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Stability and compatibility of vancomycin for administration by continuous infusion

(2013) V. Raverdy et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of Vancomycin Susceptibility Testing for Methicillin-Resistant Staphylococcus aureus: Comparison of Etest and Three Automated Testing Methods

(2013) M. J. Rybak et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Alternative Mutational Pathways to Intermediate Resistance to Vancomycin in Methicillin-Resistant Staphylococcus aureus

(2013) Celine Vidaillac et al.   JOURNAL OF INFECTIOUS DISEASES

A Randomized Controlled Trial of a Vancomycin Loading Dose in Children

(2013) Alicia Demirjian et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Desired Vancomycin Trough Serum Concentration for Treating Invasive Methicillin-resistant Staphylococcal Infections

(2013) Adam Frymoyer et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Improved Vancomycin Dosing in Children Using Area Under the Curve Exposure

(2013) Jennifer Le et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Vancomycin Dosing in Children and Young Adults: Back to the Drawing Board

(2013) Lauren Camaione et al.   PHARMACOTHERAPY

The Effect of Age and Weight on Vancomycin Serum Trough Concentrations in Pediatric Patients

(2013) Theresa Madigan et al.   PHARMACOTHERAPY

Vancomycin Trough Concentrations in Overweight or Obese Pediatric Patients

(2013) Daniel E. Heble et al.   PHARMACOTHERAPY

A Comparison of Traditional and Novel Definitions (RIFLE, AKIN, and KDIGO) of Acute Kidney Injury for the Prediction of Outcomes in Acute Decompensated Heart Failure

(2013) Andrew K. Roy et al.   CardioRenal Medicine

Retrospective review of vancomycin-induced nephrotoxicity in patients with leukemia

(2013) Amber Fullmer et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Medication Dosing in Critically Ill Patients With Acute Kidney Injury Treated With Renal Replacement Therapy

(2012) Bridget A. Scoville et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Effect of Continuous Venovenous Hemofiltration Dose on Achievement of Adequate Vancomycin Trough Concentrations

(2012) Erin N. Frazee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter

(2012) S. J. van Hal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring

(2012) W. Zhao et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Is Peak Concentration Needed in Therapeutic Drug Monitoring of Vancomycin? A Pharmacokinetic-Pharmacodynamic Analysis in Patients with Methicillin-ResistantStaphylococcus aureusPneumonia

(2012) Yosuke Suzuki et al.   CHEMOTHERAPY

Initial Vancomycin Dosing Protocol to Achieve Therapeutic Serum Concentrations in Patients Undergoing Hemodialysis

(2012) S. A. Zelenitsky et al.   CLINICAL INFECTIOUS DISEASES

Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study

(2012) V. Dubée et al.   CLINICAL MICROBIOLOGY AND INFECTION

Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools

(2012) Aline Fuchs et al.   CLINICAL PHARMACOKINETICS

Incidence of Nephrotoxicity and Association With Vancomycin Use in Intensive Care Unit Patients With Pneumonia: Retrospective Analysis of the IMPACT-HAP Database

(2012) Ennie L. Cano et al.   CLINICAL THERAPEUTICS

Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels

(2012) J. Truong et al.   INTERNAL MEDICINE JOURNAL

Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients

(2012) Eva Ocampos-Martinez et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Altered vancomycin pharmacokinetics in obese and morbidly obese patients: what we have learned over the past 30 years

(2012) E. Grace   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy of continuous infusion of vancomycin for the outpatient treatment of methicillin-resistant Staphylococcus aureus infections

(2012) A. J. Verrall et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Serum Vancomycin Levels Resulting From Continuous or Intermittent Infusion in Critically Ill Burn Patients With or Without Continuous Renal Replacement Therapy

(2012) Kevin S. Akers et al.   Journal of Burn Care & Research

Continuous intravenous administration of vancomycin in medical intensive care unit patients

(2012) Bernd Saugel et al.   JOURNAL OF CRITICAL CARE

Drug Dosing Based on Weight and Body Surface Area: Mathematical Assumptions and Limitations in Obese Adults

(2012) Manjunath P. Pai   PHARMACOTHERAPY

Evaluation of Vancomycin Dosing Regimens in Preterm and Term Neonates Using Monte Carlo Simulations

(2012) Nitin Mehrotra et al.   PHARMACOTHERAPY

Vancomycin dosage in overweight and obese children

(2011) M. Miller et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Assessment of Vancomycin Dosing and Subsequent Serum Concentrations in Pediatric Patients

(2011) Lea S Eiland et al.   ANNALS OF PHARMACOTHERAPY

Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens

(2011) Jason A. Roberts et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Applying New Diagnostic Criteria for Acute Kidney Injury To Facilitate Early Identification of Nephrotoxicity in Vancomycin-Treated Patients

(2011) Emi Minejima et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization

(2011) Jack Brown et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Longitudinal Hemodiafilter Performance in Modeled Continuous Renal Replacement Therapy

(2011) Deborah A. Pasko et al.   BLOOD PURIFICATION

Weight-Based Loading of Vancomycin in Patients on Hemodialysis

(2011) Merideth Brown et al.   CLINICAL INFECTIOUS DISEASES

Implementation of a Dose Calculator for Vancomycin to Achieve Target Trough Levels of 15-20  g/mL in Persons Undergoing Hemodialysis

(2011) S. J. Vandecasteele et al.   CLINICAL INFECTIOUS DISEASES

Vancomycin: We Can't Get There From Here

(2011) N. Patel et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

(2011) R. Kullar et al.   CLINICAL INFECTIOUS DISEASES

Vancomycin Dosing in Obese Pediatric Patients

(2011) Brady S. Moffett et al.   CLINICAL PEDIATRICS

Vancomycin

(2011) Amélie Marsot et al.   CLINICAL PHARMACOKINETICS

Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients

(2011) Weerachai Chaijamorn et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study

(2011) Janice Li et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Determination of Vancomycin and Daptomycin MICs by Different Testing Methods for Methicillin-Resistant Staphylococcus aureus

(2011) Mark C. Kruzel et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

(2011) Gary R. Matzke et al.   KIDNEY INTERNATIONAL

AKI in the ICU: definition, epidemiology, risk stratification, and outcomes

(2011) Kai Singbartl et al.   KIDNEY INTERNATIONAL

Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia

(2011) C. Hochart et al.   MEDECINE ET MALADIES INFECTIEUSES

Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit

(2011) Mitsuru Irikura et al.   PEDIATRICS INTERNATIONAL

Validation of the Effectiveness of a Vancomycin Nomogram in Achieving Target Trough Concentrations of 15–20 mg/L Suggested by the Vancomycin Consensus Guidelines

(2011) Ravina Kullar et al.   PHARMACOTHERAPY

Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline

(2010) María-Remedios Marqués-Miñana et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Vancomycin Pharmacokinetics and Pharmacodynamics during Short Daily Hemodialysis

(2010) B. S. Decker et al.   Clinical Journal of the American Society of Nephrology

Comparison of vancomycin and teicoplanin trough serum levels in patients with infected orthopedic devices: new data for old therapies

(2010) Xavier Lemaire et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Incidence and Risk Factors Influencing the Development of Vancomycin Nephrotoxicity in Children

(2010) Susan McKamy et al.   JOURNAL OF PEDIATRICS

Influence of Vancomycin on Renal Function in Critically Ill Patients after Cardiac Surgery

(2009) Doris Hutschala et al.   ANESTHESIOLOGY

Prospectively Validated Dosing Nomograms for Maximizing the Pharmacodynamics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients

(2009) F. Pea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients

(2009) Thomas P. Lodise et al.   CLINICAL INFECTIOUS DISEASES

Challenges in Developing Evidence-Based Drug Dosing Guidelines for Adults and Children Receiving Renal Replacement Therapy

(2009) B A Mueller et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections

(2009) Elizabeth D Hermsen et al.   Expert Opinion On Drug Safety

Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy

(2009) Paul R. Ingram et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Evaluation of glycopeptide use in nine French hospitals

(2009) S. Alfandari et al.   MEDECINE ET MALADIES INFECTIEUSES

Current Recommended Dosing of Vancomycin for Children With Invasive Methicillin-Resistant Staphylococcus aureus Infections Is Inadequate

(2009) Adam Frymoyer et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Once-weekly vancomycin for patients receiving high-flux hemodialysis: Table 1.

(2008) Brooke S. Crawford et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

(2008) M. Rybak et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin

(2008) T. P. Lodise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity

(2008) T. P. Lodise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections

(2008) Donald I. Hsu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy

(2008) P. R. Ingram et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Human renal function maturation: a quantitative description using weight and postmenstrual age

(2008) Malin M. Rhodin et al.   PEDIATRIC NEPHROLOGY